Business Standard

Saturday, December 21, 2024 | 02:31 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Shree Ganesh Biotech India standalone net profit rises 46.34% in the September 2022 quarter

Image

Capital Market

Sales rise 21.16% to Rs 21.76 crore

Net profit of Shree Ganesh Biotech India rose 46.34% to Rs 1.20 crore in the quarter ended September 2022 as against Rs 0.82 crore during the previous quarter ended September 2021. Sales rose 21.16% to Rs 21.76 crore in the quarter ended September 2022 as against Rs 17.96 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales21.7617.96 21 OPM %5.474.57 -PBDT1.200.82 46 PBT1.200.82 46 NP1.200.82 46

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 09 2022 | 6:03 PM IST

Explore News